Bayer is trying to capture more geographic territories, here we discuss how it worked in US and other developing markets (China, India, Middle East) and what steps it should take to become more prominent in the U.S and how it can promote itself in developing markets?
United States:
The United States is the world leader in biopharmaceutical and one of the biggest markets of pharmaceuticals research. The most of the world’s research and development in pharmaceuticals are conducting by the U.S. firms and also holds the rights of intellectual property of new medicines. More than 5,000 new medicines are currently in pipeline of biopharmaceutical that are developing around worldwide and also almost 3400 compounds currently being studied in the United
…show more content…
All new drugs of Biologics account in clinical trials for a quarter and also wait for the approval of U.S. Food and Drug Administration. OTC market growth will be determined by a population aging and customer trend to self-medication and the transfer of drugs from prescription to non-prescription or OTC status.
The U.S. market is the world’s biggest free-pricing marketplace for pharmaceuticals and has a complimentary patent and regulatory environment. The competition are very important in business because if there is a competition exist in the industry then the safety, price, efficacy and product quality are the first priority of every business. Biomedical research are supported by U.S. government and also supported the research and innovative and research base biomedical sector. Pharmaceutical industry in U.S. now is the preferred home for growth.
United States chemicals industry is also one of the biggest manufacturing industry and also helping to expand worldwide market along with domestic market as well. It plays an important role in the U.S. exporting sector of manufacturing. U.S. is global leader in chemical exports and production with almost 15 percent of world chemical